History

History

For two decades SOXX was a quiet PHLX-tracking sector ETF; the story changed three times in five years. June 2021 brought a new index methodology (broader, foundry-inclusive) plus a 26% fee cut (0.46% → 0.34%); the AI super-cycle then turned the fund into a momentum vehicle whose AUM, holdings concentration, and #1 weight rotated three times in three years. The 2025 disclosure regime (Tailored Shareholder Report + new MSCI USA broad benchmark + three additional portfolio managers) is a quieter pivot worth noticing — BlackRock is professionalising oversight on a product that now swings $20B of AUM on monthly AI sentiment. Tracking discipline has held throughout: the gap to index closes within ~30bps of the expense ratio every year, which is the only "promise" the issuer makes and the one it has kept.

1. The Narrative Arc

The ten-year return profile compresses three different regimes into one picture. Through FY2020 the fund lived inside a normal sector-cycle band of single-digit losses to mid-thirties gains, tracking PHLX SOX at 0.46%. FY2021's 108.93% spike — the largest single-year return on record — coincided with COVID-era pull-forward demand and was followed within months by the index transition. The FY2024 +53.53% / FY2025 -16.21% / CY2025 +40.71% sequence is the AI super-cycle in three acts: a melt-up, a digestion, and a re-acceleration that is still in progress as of the May 2026 reporting date.

2. What Management Emphasized — and Then Stopped Emphasizing

For a passive product, "management emphasis" is what BlackRock chooses to lead with in the shareholder report and what it quietly drops. Three themes have rotated through the front of the book.

Two patterns are worth flagging:

• CHIPS Act disappeared from the front of the book in FY2025. It was a load-bearing narrative in FY2023 (signed August 2022, fab applications underway) and FY2024 ("several different companies announced plans to seek CHIPS Act funds"). FY2025's Tailored Shareholder Report does not mention it. The political environment around the Act shifted after the November 2024 election and BlackRock dropped the talking point rather than re-justify it.
• "Inventory correction" returned in FY2025 after a one-year absence. FY2024 framed the cycle as "demand exceeded supply" with companies "working to increase capacity"; FY2025 reverted to "weak end-market demand … coupled with excess inventory from prior overproduction". Same supply chain, opposite vocabulary, twelve months apart.

3. Risk Evolution

The risk-factor section is largely boilerplate year-over-year, but the emphasis within it tells the story.

Three movements stand out:

• Single-name risk became newly visible in FY2025. When NVDA was 8.8% and rising, the FY2024 report treated concentration as a structural feature; the FY2025 prospectus calls out by name "a margin guide-down at NVIDIA, a litigation event at Broadcom" as material to the fund. The methodology hasn't changed. The willingness to enumerate the names has.
• Taiwan-strait risk appears for the first time in FY2025. Before TSMC ADR was a top-3 weight, this risk had no place in the disclosure. Now it does — a passive consequence of the index, but one that BlackRock now feels the need to highlight.
• Multiple-compression / equity-market risk fades exactly when it matters most. Heavy in FY2023 (post-2022 drawdown), light in FY2024 (during the melt-up), heavy again in FY2025 (after the 16% drawdown). The risk language is reactive, not predictive.

4. How They Handled Bad News

The fund had two clear "bad news" moments in the period: the FY2023 cyclical drawdown and the FY2025 (-16.21)% reversal. The framing of each is instructive — particularly because BlackRock cannot blame management decisions, only constituent behaviour.

The honest read: BlackRock did not pretend FY2025 was a tracking issue or a methodology issue — it named the macro causes (end-market weakness, China tariffs, ASML overcapacity) and pointed to the constituents that actually fell. The tracking gap of just 30bps versus the index was disclosed without spin. Given that an ETF's only real product is index-tracking discipline, the framing was credible.

What was not said is also worth noting:

• No discussion of why the fund still ran a 0.34% expense ratio after the broader iShares product family had moved several large core ETFs below 10bps.
• No commentary on the 2024 share split's purpose (almost certainly retail-flow optimisation as price approached $700 pre-split) — BlackRock simply executed it.
• The FY2024 warning about "tracking error widening … during a period of extreme weight concentration" appears once and is not repeated in FY2025 even though concentration remained elevated.

5. Guidance Track Record

A passive ETF makes essentially three contractual promises: (i) track the index, (ii) charge the stated fee, (iii) maintain operational integrity. Below are the only "promises that mattered to valuation" — the ones a buyer relies on.

Score: 8/10. BlackRock has executed its narrow contract — track the index, charge 34bps, distribute on schedule — with no public failures across a window that included an index transition, a fee cut, a 3-for-1 split, a 35% drawdown, a 50%+ ramp, and a regulatory-disclosure regime change. The two points off the top reflect (i) FY2024's 66bp tracking gap (~2× expected, attributable to representative-sampling drift during extreme concentration, not disclosed proactively) and (ii) the implicit "AI mega-force" marketing pitch, which is consistent with the index but exposes retail buyers to a 35% drawdown without separate risk framing.

6. What the Story Is Now

The current story is the simplest it has been since 2021: a 0.34% wrapper that delivers the U.S.-listed semiconductor complex, now with TSMC ADR and a top-10 that rotates between AI compute, memory, and analog every six months. What has been de-risked is structural — index transition complete, fee architecture stable, four-PM team in place, TSR-format disclosure aligned with new SEC rules. What still looks stretched is cyclical and concentration-driven: 58% of the fund is in ten names, the underlying P/E is 42× (per fact-sheet), and constituent leadership has rotated three times in three years. AUM has tripled in twelve months — from ~$10.8B (Mar-2025) to ~$29.6B (Apr-2026) — meaning most current holders have lived through only the up-leg of one cycle.